⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADXN News
Addex Therapeutics Ltd American Depositary Shares
ADDEX INCREASES ISSUED SHARE CAPITAL TO CREATE TREASURY SHARES
globenewswire.com
ADXN
Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia
globenewswire.com
ADXN
Addex Therapeutics Announces Executive Management Changes
globenewswire.com
ADXN
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update
globenewswire.com
ADXN
Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior
globenewswire.com
ADXN
Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
globenewswire.com
ADXN
ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027
globenewswire.com
ADXN
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
globenewswire.com
ADXN
Addex Shareholders Approve All Resolutions at Annual General Meeting
globenewswire.com
ADXN
Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ADXN